192 related articles for article (PubMed ID: 34445271)
1. Lymphoid Organ Proteomes Identify Therapeutic Efficacy Biomarkers Following the Intracavitary Administration of Curcumin in a Highly Invasive Rat Model of Peritoneal Mesothelioma.
Pouliquen DL; Boissard A; Henry C; Blandin S; Coqueret O; Guette C
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445271
[TBL] [Abstract][Full Text] [Related]
2. Proteomes of Residual Tumors in Curcumin-Treated Rats Reveal Changes in Microenvironment/Malignant Cell Crosstalk in a Highly Invasive Model of Mesothelioma.
Pouliquen DL; Malloci M; Boissard A; Henry C; Guette C
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430209
[TBL] [Abstract][Full Text] [Related]
3. Curcumin Treatment Identifies Therapeutic Targets within Biomarkers of Liver Colonization by Highly Invasive Mesothelioma Cells-Potential Links with Sarcomas.
Pouliquen DL; Boissard A; Henry C; Blandin S; Richomme P; Coqueret O; Guette C
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33207594
[TBL] [Abstract][Full Text] [Related]
4. Peripheral lymphadenopathy as the initial manifestation of malignant mesothelioma in a child.
Gong YS; Rong YT; Han WC; Zhang YC
Hum Pathol; 2013 Apr; 44(4):664-9. PubMed ID: 23313308
[TBL] [Abstract][Full Text] [Related]
5. Iron overload signature in chrysotile-induced malignant mesothelioma.
Jiang L; Akatsuka S; Nagai H; Chew SH; Ohara H; Okazaki Y; Yamashita Y; Yoshikawa Y; Yasui H; Ikuta K; Sasaki K; Kohgo Y; Hirano S; Shinohara Y; Kohyama N; Takahashi T; Toyokuni S
J Pathol; 2012 Nov; 228(3):366-77. PubMed ID: 22864872
[TBL] [Abstract][Full Text] [Related]
6. Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays.
Chapel DB; Stewart R; Furtado LV; Husain AN; Krausz T; Deftereos G
Hum Pathol; 2019 May; 87():11-17. PubMed ID: 30794891
[TBL] [Abstract][Full Text] [Related]
7. Diffuse mesothelioma of the peritoneum: a pathological study of 64 tumours treated with cytoreductive therapy.
Lee M; Alexander HR; Burke A
Pathology; 2013 Aug; 45(5):464-73. PubMed ID: 23846294
[TBL] [Abstract][Full Text] [Related]
8. Desmoplastic malignant mesothelioma originating from the peritoneum.
Takamaru H; Arimura Y; Shinomura Y
Med Oncol; 2012 Dec; 29(5):3155-6. PubMed ID: 22744710
[No Abstract] [Full Text] [Related]
9. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L
J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151
[TBL] [Abstract][Full Text] [Related]
10. NTP technical report on the toxicology and carcinogenesis studies of Elmiron (Cas No. 37319-17-8) in F344/N rats and B6C3F1 mice (Gavage Studies).
National Toxicology Program, Public Health Services, National Institutes of Health, US Department of Health and Human Services,
Natl Toxicol Program Tech Rep Ser; 2004 May; (512):7-289. PubMed ID: 15213766
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin.
De Cesare M; Cominetti D; Doldi V; Lopergolo A; Deraco M; Gandellini P; Friedlander S; Landesman Y; Kauffman MG; Shacham S; Pennati M; Zaffaroni N
Oncotarget; 2015 May; 6(15):13119-32. PubMed ID: 25948791
[TBL] [Abstract][Full Text] [Related]
12. Comparative proteomic analysis of human malignant ascitic fluids for the development of gastric cancer biomarkers.
Jin J; Son M; Kim H; Kim H; Kong SH; Kim HK; Kim Y; Han D
Clin Biochem; 2018 Jun; 56():55-61. PubMed ID: 29654727
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical Evaluation of Minichromosome Maintenance Protein 7 (MCM7), Topoisomerase IIα, and Ki-67 in Diffuse Malignant Peritoneal Mesothelioma Patients Using Tissue Microarray.
Deraco M; Cabras A; Baratti D; Kusamura S
Ann Surg Oncol; 2015 Dec; 22(13):4344-51. PubMed ID: 25777091
[TBL] [Abstract][Full Text] [Related]
14. AHNAK is highly expressed and plays a key role in cell migration and invasion in mesothelioma.
Sudo H; Tsuji AB; Sugyo A; Abe M; Hino O; Saga T
Int J Oncol; 2014 Feb; 44(2):530-8. PubMed ID: 24253341
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of intracavitary administration of curcumin for the treatment of sarcomatoid mesothelioma.
Pouliquen DL; Nawrocki-Raby B; Nader J; Blandin S; Robard M; Birembaut P; Grégoire M
Oncotarget; 2017 Aug; 8(34):57552-57573. PubMed ID: 28915695
[TBL] [Abstract][Full Text] [Related]
16. Cyclic nucleotide concentrations in asbestos-induced rat peritoneal mesothelioma.
Stevens RH; Will LA; Cole DA; Meek ES; Frank CW; Donham KJ
Environ Res; 1979 Aug; 19(2):442-8. PubMed ID: 227674
[No Abstract] [Full Text] [Related]
17. Curcumin C3 complex®/Bioperine® has antineoplastic activity in mesothelioma: an in vitro and in vivo analysis.
Di Meo F; Filosa S; Madonna M; Giello G; Di Pardo A; Maglione V; Baldi A; Crispi S
J Exp Clin Cancer Res; 2019 Aug; 38(1):360. PubMed ID: 31419989
[TBL] [Abstract][Full Text] [Related]
18. The secretome signature of malignant mesothelioma cell lines.
Manfredi M; Martinotti S; Gosetti F; Ranzato E; Marengo E
J Proteomics; 2016 Aug; 145():3-10. PubMed ID: 26921831
[TBL] [Abstract][Full Text] [Related]
19. Curcumin induces apoptosis and inhibits angiogenesis in murine malignant mesothelioma.
Zhang C; Hao Y; Wu L; Dong X; Jiang N; Cong B; Liu J; Zhang W; Tang D; De Perrot M; Zhao X
Int J Oncol; 2018 Dec; 53(6):2531-2541. PubMed ID: 30272283
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle tumor localization, disruption of autophagosomal trafficking, and prolonged drug delivery improve survival in peritoneal mesothelioma.
Liu R; Colby AH; Gilmore D; Schulz M; Zeng J; Padera RF; Shirihai O; Grinstaff MW; Colson YL
Biomaterials; 2016 Sep; 102():175-86. PubMed ID: 27343465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
